home / stock / nbix / nbix news


NBIX News and Press, Neurocrine Biosciences Inc. From 05/04/21

Stock Information

Company Name: Neurocrine Biosciences Inc.
Stock Symbol: NBIX
Market: NASDAQ
Website: neurocrine.com

Menu

NBIX NBIX Quote NBIX Short NBIX News NBIX Articles NBIX Message Board
Get NBIX Alerts

News, Short Squeeze, Breakout and More Instantly...

NBIX - Neurocrine Biosciences to Present at the Bank of America 2021 Healthcare Conference

Neurocrine Biosciences to Present at the Bank of America 2021 Healthcare Conference PR Newswire SAN DIEGO , May 4, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America 2021 Healthcare Conference at 11:00 a.m....

NBIX - Neurocrine Biosciences Supports Mental Health Month and Tardive Dyskinesia Awareness Week

Neurocrine Biosciences Supports Mental Health Month and Tardive Dyskinesia Awareness Week - Mental Health Advocacy Community Recognizes and Over 40 States Declare First Week of May (2-8) Tardive Dyskinesia Awareness Week to Raise Awareness of this Burdensome and Often Misunderst...

NBIX - Neurocrine Biosciences and Sentia Medical ink research collaboration agreement

Neurocrine Biosciences (NBIX) and Sentia Medical Sciences have entered into a research collaboration to discover novel, long-acting corticotropin-releasing factor ((CRF)) receptor antagonist peptide therapeutics.The collaboration will leverage Sentia’s proprietary peptide-based platfor...

NBIX - Sentia Medical Sciences and Neurocrine Biosciences Enter into Strategic Collaboration to Discover Novel CRF Peptides

SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Sentia Medical Sciences Inc. today announced that they have entered into a research collaboration with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) aimed at discovering novel, long-acting corticotropin-releasing factor (CRF) receptor antagonist p...

NBIX - Biotechs Aligning to Address Challenges for Developing Therapeutics for Billion Dollar Neurological Disorders Industry

Palm Beach, FL – April 22, 2021 – There are more than 600 types of neuro-disorders affecting the brain, spine, or nerves. Although some prevalent disorders such as cerebral stroke, Alzheimer’s disease, Parkinson’s disease, brain tumors, and epilepsy, are well-stu...

NBIX - Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors

Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors PR Newswire SAN DIEGO , April 16, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Johanna Mercier to its Board of Directo...

NBIX - Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 5 PR Newswire SAN DIEGO , April 14, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) ...

NBIX - Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73rd 2021 Virtual Meeting

Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73rd 2021 Virtual Meeting PR Newswire SAN DIEGO , April 8, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it wil...

NBIX - Best Stocks To Buy In April 2021? 4 Biotech Stocks To Watch This Week

Do You Have These Trending Biotech Stocks On Your Watchlist This Week? Biotech companies play a major role in advancing longevity and medicine, even more so as we recover from the coronavirus pandemic. It is this importance that made biotech stocks a major hit among investors, a...

NBIX - Top Health Care Stocks Worth Investing In Now? 4 In Focus

Are These The Best Health Care Stocks To Buy Before April 2021? No matter the state of the world, the health care industry will likely continue to work towards improving our quality of life. With this being the case, it would make sense then that investors are turning to health ca...

Previous 10 Next 10